BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33024014)

  • 1. Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria.
    Mor DE; Sohrabi S; Kaletsky R; Keyes W; Tartici A; Kalia V; Miller GW; Murphy CT
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26438-26447. PubMed ID: 33024014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson's models.
    Kim H; Perentis RJ; Caldwell GA; Caldwell KA
    Cell Death Dis; 2018 May; 9(5):555. PubMed ID: 29748634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced branched-chain amino acid metabolism improves age-related reproduction in C. elegans.
    Lesnik C; Kaletsky R; Ashraf JM; Sohrabi S; Cota V; Sengupta T; Keyes W; Luo S; Murphy CT
    Nat Metab; 2024 Apr; 6(4):724-740. PubMed ID: 38418585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
    Ray A; Martinez BA; Berkowitz LA; Caldwell GA; Caldwell KA
    Cell Death Dis; 2014 Jan; 5(1):e984. PubMed ID: 24407237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zearalenone Induces Dopaminergic Neurodegeneration via DRP-1-Involved Mitochondrial Fragmentation and Apoptosis in a
    Wei CC; Yang NC; Huang CW
    J Agric Food Chem; 2021 Oct; 69(40):12030-12038. PubMed ID: 34586801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K; Tandon A; Rezai P
    Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age- and manganese-dependent modulation of dopaminergic phenotypes in a C. elegans DJ-1 genetic model of Parkinson's disease.
    Chen P; DeWitt MR; Bornhorst J; Soares FA; Mukhopadhyay S; Bowman AB; Aschner M
    Metallomics; 2015 Feb; 7(2):289-98. PubMed ID: 25531510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson's disease.
    Saewanee N; Praputpittaya T; Malaiwong N; Chalorak P; Meemon K
    Neurosci Res; 2021 Jan; 162():13-21. PubMed ID: 31881233
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson's disease models.
    Cooper JF; Machiela E; Dues DJ; Spielbauer KK; Senchuk MM; Van Raamsdonk JM
    Sci Rep; 2017 Nov; 7(1):16441. PubMed ID: 29180793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modulators associated with regulatory surveillance of mitochondrial quality control, play a key role in regulating stress pathways and longevity in C. elegans.
    Sarkar A; Hameed R; Mishra A; Bhatta RS; Nazir A
    Life Sci; 2022 Feb; 290():120226. PubMed ID: 34953889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.
    Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer JA; Tardiff DF; Strathearn KE; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell KA; Bell GW; Fraenkel E; Cooper AA; Caldwell GA; McCaffery JM; Rochet JC; Lindquist S
    Dis Model Mech; 2010; 3(3-4):194-208. PubMed ID: 20038714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential anti-Parkinsonian's effect of S-(+)-linalool from Cinnamomum osmophloeum ct. linalool leaves are associated with mitochondrial regulation via gas-1, nuo-1, and mev-1 in Caenorhabditis elegans.
    Chang CH; Chang ST; Liao VH
    Phytother Res; 2022 Aug; 36(8):3325-3334. PubMed ID: 35665972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic stress is a primary pathogenic event in transgenic
    Teo E; Ravi S; Barardo D; Kim HS; Fong S; Cazenave-Gassiot A; Tan TY; Ching J; Kovalik JP; Wenk MR; Gunawan R; Moore PK; Halliwell B; Tolwinski N; Gruber J
    Elife; 2019 Oct; 8():. PubMed ID: 31610847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.
    Langley M; Ghosh A; Charli A; Sarkar S; Ay M; Luo J; Zielonka J; Brenza T; Bennett B; Jin H; Ghaisas S; Schlichtmann B; Kim D; Anantharam V; Kanthasamy A; Narasimhan B; Kalyanaraman B; Kanthasamy AG
    Antioxid Redox Signal; 2017 Nov; 27(14):1048-1066. PubMed ID: 28375739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging neuroprotective effect of metformin in Parkinson's disease: A molecular crosstalk.
    Paudel YN; Angelopoulou E; Piperi C; Shaikh MF; Othman I
    Pharmacol Res; 2020 Feb; 152():104593. PubMed ID: 31843673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
    Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R
    Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.